¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"contraction band necrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • radiation necrosis
    ¹æ»ç¼±±«»ç
  • renal cortical necrosis
    ÄáÆÏ°ÑÁú±«»ç, ½ÅÀåÇÇÁú±«»ç
  • renal papillary necrosis
    ÄáÆÏÀ¯µÎ±«»ç, ½ÅÀåÀ¯µÎ±«»ç
  • subacute hepatic necrosis
    ¾Æ±Þ¼º°£±«»ç
  • subcutaneous fat necrosis
    ÇǺιØÁö¹æ±«»ç, ÇÇÇÏÁö¹æ±«»ç
  • zonal necrosis
    ±¸¿ª±«»ç
  • atrial contraction
    ½É¹æ¼öÃà
  • aerobic contraction
    »ê¼Ò¼º¼öÃà
  • anaerobic contraction
    ¹«»ê¼Ò¼º¼öÃà
  • bladder contraction
    ¹æ±¤¼öÃà
  • concentric contraction
    µ¿½É¼öÃà
  • contraction
    ¼öÃà
  • contraction fold
    ¼öÃàÁÖ¸§
  • contraction stress test
    ¼öÃàÀڱذ˻ç
  • excitation contraction coupling
    ÈïºÐ¼öÃà°áÇÕ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • renal papillary necrosis
    ÄáÆÏÀ¯µÎ±«»ç
  • subacute hepatic necrosis
    ¾Æ±Þ¼º°£±«»ç
  • subcutaneous fat necrosis
    ÇǺιØÁö¹æ±«»ç, ÇÇÇÏÁö¹æ±«»ç
  • traumatic fat necrosis
    ¿Ü»óÁö¹æ±«»ç
  • tubular necrosis
    ¿ä¼¼°ü±«»ç
  • aerobic contraction
    È£±â¼öÃà
  • anaerobic contraction
    Çø±â¼öÃà
  • atrial contraction
    ½É¹æ¼öÃà
  • auricular contraction
    (¢¡atrial contraction) ½É¹æ¼öÃà
  • contraction
    ¼öÃà
  • co-contraction syndrome
    µ¿½Ã¼öÃàÁõÈıº
  • concentric contraction
    (¢¡shortening contraction) ´ÜÃà¼öÃà, ª¾ÆÁü¼öÃà
  • contraction fold
    ¼öÃàÁÖ¸§
  • contraction stress test
    ¼öÃàÀڱذ˻ç
  • eccentric contraction
    (¢¡lengthening contraction) ½ÅÀå¼öÃà, ´ÃÀÓ¼öÃà
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • soldered band
    ³³Âø´ë(ÕÄó·Óá).
  • sonolucent band
    ÃÊÀ½ÆÄ Åõ°ú¼º (õ±ëå÷î ÷âΦàõ) ¶ì
  • sonolucent band
    ÃÊÀ½ÆÄ Åõ°ú¼º ¶ì
  • sternal band
    Èä°ñ´ë(ýØÍéÓá).
  • superior band of cruciform ligament
    ½ÊÀÚÀδëÀÇ Á¾¼Ó.
  • tooth band
    Ä¡Á¦(öÍð§).
  • trabecular pigment band
    ¼¶À¯ÁÖ»ö¼Ò¶ì
  • ventricular band
    °¡¼º´ë
  • ventricular band
    °¡¼º´ë(Ê£á¢Óá).
  • aerobic contraction
    È£±â¼º ¼öÃà(¡­â¥õê)
  • anaerobic contraction
    Çø±â¼º ¼öÃà(¡­â¥õê)
  • atrial contraction
    (½É)¹æ¼öÃà(ãýÛ®â¥õê)
  • atrial premature contraction
    ½É¹æ(¼º) ±â¿Ü¼öÃà(¡­Ñ¢èââ¥õê).
  • auricular contraction
    ½É¹æ¼öÃà
  • automatic ventricular contraction
    ÀÚµ¿½É½Ç¼öÃà(¡­ãýãøâ¥õê).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
TNF Tumor Necrosis Factor; Á¾¾ç ±«»ç ÀÎÀÚ
AEN aseptic epiphyseal necrosis
ANB avascular necrosis of bone
ASHN acute sclerosing hyaline necrosis
ATN acute tubular necrosis; augmented transition network
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
Fc Force of contraction
ICT Isovolumetric contraction time
Ict Isovolumic contraction time
MVC Maximal voluntary contraction
MVIC Maximal voluntary isometric contraction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • band contouring plier
    ´ëȯºÎÇü °âÀÚ
  • band form
    ´ë»óü, °£»ó, °£»ó ¼¼Æ÷, ´ë»óÇü
  • band keratopathy
    ´ë»ó °¢¸·Áõ, ¶ì ¸ð¾ç °¢¸·º´Áõ, ´ë»ó °¢¸·º´Áõ
    °Ë¿­¿¡ »ó´çÇÏ´Â ºÎºÐÀÇ °¢¸·¿¡ ´ë»óÀÇ È¸¹é»ö ȥŹÀÌ »ý±â´Â °ÍÀ¸·Î¼­, ȥŹÀÇ ºÎÀ§´Â Bowman¸· ºÎ±Ù.
  • band noise
    ´ë¿ª ÀâÀ½
  • band of Hunter-Schreger
    ÇåÅÍ-½¬·¹°Å´ë
    »ç¶÷ÀÇ Ä¡¾Æ Á¾´Ü¸éÀÇ ¹ý¶ûÁú ¼Ó¿¡ ÀÖÀ¸¸ç ¹Ý»ç±¤À¸·Î °üÂûµÈ´Ù.
  • band pusher
    ´ëȯ ÃßÁø±â
  • band splint
    ´ëȯ ºÎ¸ñ
  • band-loop space maintainer
    ¹êµå·ç¿ìÇÁ º¸°ÝÀåÄ¡
  • band-shaped keratopathy
    ¶ì ¸ð¾ç °¢¸·º´Áõ, ´ë»ó °¢¸· º´Áõ
  • belly band
    º¹´ë
    º¹ºÎ¸¦ µÑ·¯¸Å´Â ¶ì·Î¼­, º¸Åë Á¥¸ÔÀÌ È¤Àº À¯¾Æ¿¡ »ç¿ëÇÑ´Ù.
  • C-band
    c-´ë
    ÀÌ¿°»öÁúÀÇ ¿°»ö¹ý¿¡ ÀÇÇÏ¿© ³ªÅ¸³ª´Â ¿°»öü¿¡ Çü¼ºµÈ ´ë.
  • Clado's band
    Ŭ¶óµµ Àδë
    º¹¸·À¸·Î µ¤¾î ½ÎÀÎ ³­¼ÒÀÇ Á¦»è.
  • clamp band
    ±Ý¼ÓÁ¦ °íÁ¤ ´ëȯ
    ³ª»ç º¼Æ®¿Í ³ÊÆ®¸¦ ÀûÀýÇÏ°Ô ÀÌ¿ëÇÑ °íÁ¤ ´ëȯ.
  • coagulation band
    ÀÀ°í´ë
    Weltmann ÀÀ°í ½ÃÇè¿¡¼­ Çü¼ºµÈ ÀÀ°í´ë.
  • contoured band
    À±°û ´ë°ü
    Ä¡¾ÆÀÇ ¿ÜÇü¿¡ ÀûÇÕÇϵµ·Ï ¸¸µç Ä¡°ú¿ë ´ëȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
necrosis <pathology> The sum of the morphological changes indicative of cell death and caused by the progressive degradative action of enzymes, it may affect groups of cells or part of a structure or an organ.
Origin: Gr. Nekrosis = deadness
(18 Nov 1997)
necrosis bacillus A species of gram-negative, non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood.
(12 Dec 1998)
subcutaneous fat necrosis of newborn Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum.
(05 Mar 2000)
suppurative necrosis Liquefactive necrosis with pus formation.
(05 Mar 2000)
dental pulp necrosis Death of pulp tissue. When the necrosis is due to ischemia with superimposed bacterial infection, it is referred to as pulp gangrene.
(12 Dec 1998)
infectious pancreatic necrosis virus The type species of aquabirnavirus, causing infectious pancreatic necrosis in salmonid fish and other freshwater and marine animals including mollusks.
(12 Dec 1998)
ischemic necrosis Necrosis caused by hypoxia resulting from local deprivation of blood supply, as by infarction.
(05 Mar 2000)
total necrosis Complete necrosis of the cytologic and histologic elements in a portion of tissue, as in caseous necrosis, death of an entire organ or part.
(05 Mar 2000)
epiphysial aseptic necrosis Aseptic necrosis of bony epiphyses, probably due to ischemia; it may affect the upper end of the femur (Legg-Calve-Perthes disease), the tibial tubercle (Osgood-Schlatter disease), the tarsal navicular bone or the patella (Kohler's disease), the second metatarsal head (Freiberg's disease), vertebral bodies (Scheuermann's disease), or the capitellum of the humerus (Panner's disease).
(05 Mar 2000)
tumor necrosis factor <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin.
Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine.
Synonym: cachectin.
Acronym: TNF
(13 Nov 1997)
tumour necrosis factor <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin.
Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine.
Synonym: cachectin.
Acronym: TNF
(13 Nov 1997)
tumour necrosis factor-beta <cytokine> A cytolytic factor that is produced by CD4 and CD8 T-cells after their exposure to an antigen.
(05 Mar 2000)
kidney cortex necrosis The death of all the functioning renal cells of the kidney cortex with continued viability of the majority of the medullary units. It is due usually to the arterial distribution peculiar to the kidney which makes the renal cortex more susceptible to diminished blood flow.
(12 Dec 1998)
kidney papillary necrosis A form of acute kidney disease characterised by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual aetiologic agents.
(12 Dec 1998)
kidney tubular necrosis, acute Acute kidney failure resulting from destruction of tubular epithelial cells. It is commonly attributed to exposure to toxic agents or renal ischemia following severe trauma.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á